Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP922473.RA8_Ix2OxtI4uV3ymxhSxBi9SkA_FvG343n_AHXoc4tfo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP922473.RA8_Ix2OxtI4uV3ymxhSxBi9SkA_FvG343n_AHXoc4tfo130_assertion type Assertion NP922473.RA8_Ix2OxtI4uV3ymxhSxBi9SkA_FvG343n_AHXoc4tfo130_head.
- NP922473.RA8_Ix2OxtI4uV3ymxhSxBi9SkA_FvG343n_AHXoc4tfo130_assertion description "[We have studied the mutational status of TET2 (complete coding region), ASXL1 (exon12), IDH1 (R132), IDH2 (R140 and R172), and c-CBL (exons 8 and 9) in 62 MPN patients (52 essential thrombocythemia (ET), five polycythemia vera (PV), and five primary myelofibrosis (PMF)) negative for both JAK2 (V617F and exon 12) and MPL (exon 10) mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP922473.RA8_Ix2OxtI4uV3ymxhSxBi9SkA_FvG343n_AHXoc4tfo130_provenance.
- NP922473.RA8_Ix2OxtI4uV3ymxhSxBi9SkA_FvG343n_AHXoc4tfo130_assertion evidence source_evidence_literature NP922473.RA8_Ix2OxtI4uV3ymxhSxBi9SkA_FvG343n_AHXoc4tfo130_provenance.
- NP922473.RA8_Ix2OxtI4uV3ymxhSxBi9SkA_FvG343n_AHXoc4tfo130_assertion SIO_000772 21904853 NP922473.RA8_Ix2OxtI4uV3ymxhSxBi9SkA_FvG343n_AHXoc4tfo130_provenance.
- NP922473.RA8_Ix2OxtI4uV3ymxhSxBi9SkA_FvG343n_AHXoc4tfo130_assertion wasDerivedFrom befree-2016 NP922473.RA8_Ix2OxtI4uV3ymxhSxBi9SkA_FvG343n_AHXoc4tfo130_provenance.
- NP922473.RA8_Ix2OxtI4uV3ymxhSxBi9SkA_FvG343n_AHXoc4tfo130_assertion wasGeneratedBy ECO_0000203 NP922473.RA8_Ix2OxtI4uV3ymxhSxBi9SkA_FvG343n_AHXoc4tfo130_provenance.